AI could take 'years' off the drug development process, says Bausch + Lomb CEO Brent Saunders

Bausch + Lomb CEO Brent Saunders joins 'Squawk on the Street' to discuss the impacts of artificial intelligence on healthcare, the company's latest earnings report, and more.